Novartis Investigative Site

Passaic, New Jersey 07055

0 studies enrolling now · 1 studies all time

What they study most

Spondylitis, Ankylosing

Studies at this site

• 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients — Completed